• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种使用临床因素估计成人发病 1 型糖尿病部分临床缓解概率的在线工具。

An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetes.

机构信息

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Sydney Pharmacy School, University of Sydney, Sydney, NSW, Australia.

Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poland.

出版信息

J Diabetes Complications. 2024 Sep;38(9):108828. doi: 10.1016/j.jdiacomp.2024.108828. Epub 2024 Jul 27.

DOI:10.1016/j.jdiacomp.2024.108828
PMID:39084177
Abstract

A type 1 diabetes (T1D) diagnosis is often followed by a period of reduced exogenous insulin requirement, with acceptable glucose control, called partial clinical remission (pCR). Various criteria exist to define pCR, which is associated with better clinical outcomes. We aimed to develop formulae and a related online calculator to predict the probability of pCR at 3- and 12-months post-T1D diagnosis. We analysed data from 133 adults at their T1D diagnosis (mean ± SD age: 27 ± 6 yrs., HbA1c 11.1 ± 2.0 %, 98 ± 22 mmol/mol), 3- and 12-months later. All patients were enrolled in the prospective observational InLipoDiab1 study (NCT02306005). We compared four definitions of pCR: 1) stimulated C-peptide >300 pmol/l; 2) insulin dose-adjusted HbA1c ≤9 %; 3) insulin dose <0.3 IU/kg/24 h; and HbA1c ≤6.4 % (46 mmol/mol); and 4) insulin dose <0.5 IU/kg/24 h and HbA1c <7 % (53 mmol/mol). Using readily available demographics and clinical chemistry data exhaustive search methodology was used to model pCR probability. There was low concordance between pCR definitions (kappa 0.10). The combination of age, HbA1c, diastolic blood pressure, triglycerides and smoking at T1D onset predicted pCR at 12-months with an area under the curve (AUC) = 0.87. HbA1c, triglycerides and insulin dose 3-mths post-diagnosis had an AUC = 0.89. A related calculator for pCR in adult-onset T1D is available at http://www.bit.ly/T1D-partial-remission.

摘要

1 型糖尿病(T1D)诊断后通常会出现一段时间的外源性胰岛素需求减少,同时血糖控制可接受,称为部分临床缓解(pCR)。存在各种定义 pCR 的标准,其与更好的临床结果相关。我们旨在开发公式和相关在线计算器,以预测 T1D 诊断后 3 个月和 12 个月时 pCR 的概率。我们分析了来自 133 名成年人在 T1D 诊断时的数据(平均 ± 标准差年龄:27 ± 6 岁,HbA1c 11.1 ± 2.0%,98 ± 22 mmol/mol),3 个月和 12 个月后。所有患者均纳入前瞻性观察性 InLipoDiab1 研究(NCT02306005)。我们比较了 pCR 的四种定义:1)刺激 C 肽>300 pmol/l;2)胰岛素剂量调整后的 HbA1c ≤9%;3)胰岛素剂量<0.3 IU/kg/24 h;和 HbA1c ≤6.4%(46 mmol/mol);4)胰岛素剂量<0.5 IU/kg/24 h 和 HbA1c <7%(53 mmol/mol)。使用易于获得的人口统计学和临床化学数据,采用穷举搜索方法对 pCR 概率进行建模。pCR 定义之间的一致性较低(kappa 0.10)。T1D 发病时的年龄、HbA1c、舒张压、甘油三酯和吸烟的组合可预测 12 个月时的 pCR,曲线下面积(AUC)为 0.87。诊断后 3 个月的 HbA1c、甘油三酯和胰岛素剂量的 AUC 为 0.89。成人发病的 T1D 中 pCR 的相关计算器可在 http://www.bit.ly/T1D-partial-remission 获得。

相似文献

1
An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetes.一种使用临床因素估计成人发病 1 型糖尿病部分临床缓解概率的在线工具。
J Diabetes Complications. 2024 Sep;38(9):108828. doi: 10.1016/j.jdiacomp.2024.108828. Epub 2024 Jul 27.
2
Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis.在诊断为 1 型糖尿病后长达 12 个月的时间内,评估儿童和成人部分缓解状态与个体和糖尿病表现特征的关系:ADDRESS-2(诊断后糖尿病研究支持系统-2)研究分析。
Diabetes Res Clin Pract. 2019 Sep;155:107789. doi: 10.1016/j.diabres.2019.107789. Epub 2019 Jul 19.
3
Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.1 型糖尿病发病后首年之外的青少年患者的临床结局:儿科糖尿病联盟(PDC)1 型糖尿病新发(NeOn)研究结果。
Pediatr Diabetes. 2017 Nov;18(7):566-573. doi: 10.1111/pedi.12459. Epub 2016 Oct 19.
4
Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.1型糖尿病的部分临床缓解:比较每日胰岛素总剂量<0.3单位/千克/天与检测部分临床缓解的金标准即胰岛素剂量调整糖化血红蛋白≤9%的准确性。
J Pediatr Endocrinol Metab. 2017 Aug 28;30(8):823-830. doi: 10.1515/jpem-2017-0019.
5
Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.1 型糖尿病诊断时采用连续皮下胰岛素输注与多次皮下注射胰岛素治疗儿童和青少年:SCIPI RCT。
Health Technol Assess. 2018 Aug;22(42):1-112. doi: 10.3310/hta22420.
6
Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.1型糖尿病部分缓解的相关因素:基于德国和奥地利3657名儿童及青少年胰岛素剂量调整后的糖化血红蛋白分析
Pediatr Diabetes. 2017 Sep;18(6):428-434. doi: 10.1111/pedi.12413. Epub 2016 Jul 15.
7
Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study.儿童 1 型糖尿病部分缓解期胰岛素敏感性的差异:一项纵向队列研究。
Diabet Med. 2022 Feb;39(2):e14702. doi: 10.1111/dme.14702. Epub 2021 Oct 6.
8
Partial Clinical Remission of Type 1 Diabetes in Swedish Children: A Longitudinal Study from the Swedish National Quality Register (SWEDIABKIDS) and the Better Diabetes Diagnosis (BDD) Study.1 型糖尿病的部分临床缓解:来自瑞典国家质量登记处(SWEDIABKIDS)和更好的糖尿病诊断(BDD)研究的纵向研究。
Diabetes Technol Ther. 2024 Nov;26(11):851-861. doi: 10.1089/dia.2024.0112. Epub 2024 Jun 26.
9
Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes.部分缓解的定义:基于胰岛素剂量调整后的糖化血红蛋白(IDAA1C)对129名丹麦新发1型糖尿病儿童进行验证。
Pediatr Diabetes. 2014 Nov;15(7):469-76. doi: 10.1111/pedi.12208.
10
Clinical outcomes of a real-world prospective study using Dexcom ONE continuous glucose monitoring in people with diabetes treated with two or more insulin injections per day.一项针对每天接受两次或更多次胰岛素注射治疗的糖尿病患者使用德康ONE连续血糖监测的真实世界前瞻性研究的临床结果。
Diabet Med. 2025 Apr;42(4):e15519. doi: 10.1111/dme.15519. Epub 2025 Jan 28.